EUVIMEDEUVIMED entdecken
Crossref

Exploring Chalcone Derivatives Against Alzheimer’s Disease: Biological Activity and Structure–Activity Relationships

Shashi Prabha, Sobhit Singh Rajput

Synlett · 01.01.2026 · 37 (01) · 67-75

DOI: 10.1055/a-2690-9342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synlett, erschienen am 01.01.2026. Verfasst von Shashi Prabha und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chalcone is a versatile scaffold that has gained attention for its potential in developing treatments for Alzheimer’s disease (AD). This review highlights recent progress in the design and evaluation of chalcone hybrids and derivatives with anti-Alzheimer activity, particularly against key enzymes such as acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidases (MAO-A and MAO-B). Many of these compounds show promising inhibition, suggesting their potential to improve cholinergic transmission and reduce neurodegeneration. Structure–activity relationship (SAR) studies reveal that substitution patterns on aromatic rings strongly influence activity. Oxindole-based chalcone analogues (5) were good AChE inhibitors, while chalcone–rivastigmine hybrids (11) were excellent BChE inhibitors. For MAO-B, 4-aminochalcone–rivastigmine hybrids (10) and morpholine-based chalcone hybrids (20) were potent inhibitors. Molecular docking studies further explain how these molecules interact with target enzymes, supporting their biological relevance. The combination of pharmacophores with the chalcone core has also improved selectivity and potency. Overall, the findings summarized in this review suggest that chalcone-based compounds are promising candidates for further development as anti-Alzheimer agents. With their multitarget potential and ease of structural modification, chalcones represent a valuable pharmacophore for addressing the complex pathology of AD. Future work focusing on rational design and computational tools may enable the discovery of effective therapies.

Zitieren

APA

Prabha, S., & Rajput, S. S. (2026). Exploring Chalcone Derivatives Against Alzheimer’s Disease: Biological Activity and Structure–Activity Relationships. Synlett, 37(01), 67-75. https://doi.org/10.1055/a-2690-9342

Vancouver

Prabha S, Rajput SS. Exploring Chalcone Derivatives Against Alzheimer’s Disease: Biological Activity and Structure–Activity Relationships. Synlett. 2026;37(01):67-75. doi:10.1055/a-2690-9342

BibTeX
@article{Prabha2026,
  author = {Prabha, Shashi and Rajput, Sobhit Singh},
  title = {Exploring Chalcone Derivatives Against Alzheimer’s Disease: Biological Activity and Structure–Activity Relationships},
  journal = {Synlett},
  year = {2026},
  volume = {37},
  number = {01},
  pages = {67--75},
  doi = {10.1055/a-2690-9342}
}
Kostenlos starten →